Literature DB >> 19284805

A blueprint for pharmacy benefit managers to increase value.

William H Shrank1, Michael E Porter, Sachin H Jain, Niteesh K Choudhry.   

Abstract

Pharmacy benefit managers (PBMs) have a unique opportunity to promote health and generate value in the healthcare system. Today, PBMs are largely evaluated on their ability to control costs rather than improve health. Pharmacy benefit managers should be evaluated along 3 dimensions in which they can increase value: (1) use of cost-effective medications, (2) timely initiation of appropriate medication therapy, and (3) adherence to that therapy. Value creation requires the development of integrated data systems, stronger partnerships with patients and physicians, and improved measurement and reporting of results. Incentives for PBMs to promote value should drive innovation and improve health outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 19284805      PMCID: PMC2737824     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  22 in total

1.  Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Authors:  Michael A Fischer; Sebastian Schneeweiss; Jerry Avorn; Daniel H Solomon
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

Review 2.  The role of PBMs in implementing the Medicare prescription drug benefit.

Authors:  Robert F Atlas
Journal:  Health Aff (Millwood)       Date:  2004 Jul-Dec       Impact factor: 6.301

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

4.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

5.  Persistence with treatment for hypertension in actual practice.

Authors:  J J Caro; M Salas; J L Speckman; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

6.  The quality of pharmacologic care for adults in the United States.

Authors:  William H Shrank; Steven M Asch; John Adams; Claude Setodji; Eve A Kerr; Joan Keesey; Shaista Malik; Elizabeth A McGlynn
Journal:  Med Care       Date:  2006-10       Impact factor: 2.983

7.  Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

Authors:  Jennifer S Haas; Kathryn A Phillips; Eric P Gerstenberger; Andrew C Seger
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

8.  The effect of incentive-based formularies on prescription-drug utilization and spending.

Authors:  Haiden A Huskamp; Patricia A Deverka; Arnold M Epstein; Robert S Epstein; Kimberly A McGuigan; Richard G Frank
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

Review 9.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

10.  The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.

Authors:  William H Shrank; Tuyen Hoang; Susan L Ettner; Peter A Glassman; Kavita Nair; Dee DeLapp; June Dirstine; Jerry Avorn; Steven M Asch
Journal:  Arch Intern Med       Date:  2006-02-13
View more
  3 in total

1.  Recent trends in the dispensing of 90-day-supply prescriptions at retail pharmacies: implications for improved convenience and access.

Authors:  Joshua N Liberman; Charmaine Girdish
Journal:  Am Health Drug Benefits       Date:  2011-03

2.  Not at All Effective: Differences in Views on the Causes of Prescription Non-adherence Between North Korean Defectors and Medical Providers in South Korea.

Authors:  Soo Jung Hong
Journal:  J Immigr Minor Health       Date:  2015-06

Review 3.  Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.

Authors:  Trevor J Royce; Caroline Schenkel; Kelsey Kirkwood; Laura Levit; Kathryn Levit; Sheetal Kircher
Journal:  JCO Oncol Pract       Date:  2020-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.